Share:
Bill Information - History
House Bill 45; Regular Session 2017-2018
Sponsors:
GODSHALL, BARRAR, BOBACK, V. BROWN, CALTAGIRONE, CAUSER, D. COSTA, COX, DIAMOND, FRANKEL, GILLESPIE, A. HARRIS, JAMES, W. KELLER, KINSEY, LONGIETTI, MARSHALL, MILLARD, MOUL, MULLERY, MURT, NEILSON, O'BRIEN, ORTITAY, PICKETT, QUIGLEY, READSHAW, SCHLOSSBERG, SIMMONS, TOEPEL, WARD, WATSON, ZIMMERMAN, GABLER, KAUFFMAN, DeLUCA, D. MILLER, WARREN, PHILLIPS-HILL, BARBIN, FARRY, KORTZ, RAVENSTAHL and JOZWIAK
Short Title:
An Act providing for the use of investigational drugs, biological products and medical devices by terminally ill patients.
Actions:
| PN 0051 | Referred to HUMAN SERVICES, Jan. 23, 2017 |
|
| PN 1051 | Reported as amended, March 22, 2017 |
|
Removed from table, April 4, 2017 |
||
| PN 1264 | Second consideration, with amendments, April 5, 2017 |
|
Re-committed to APPROPRIATIONS, April 5, 2017 |
||
Re-reported as committed, April 18, 2017 |
||
Third consideration and final passage, April 18, 2017 (193-0) |
||
In the Senate |
||
Referred to HEALTH AND HUMAN SERVICES, April 20, 2017 |
||
| PN 2108 | Reported as amended, June 21, 2017 |
|
Removed from table, July 26, 2017 |
||
Third consideration and final passage, Oct. 2, 2017 (49-0) |
||
In the House |
||
Referred to RULES, Oct. 3, 2017 |
||
Re-reported on concurrence, as committed, Oct. 3, 2017 |
||
House concurred in Senate amendments, Oct. 4, 2017 (198-0) |
||
Signed in House, Oct. 4, 2017 |
||
Signed in Senate, Oct. 4, 2017 |
||
Presented to the Governor, Oct. 5, 2017 |
||
Approved by the Governor, Oct. 11, 2017 |
||
Act No. 33 of 2017, Oct. 11, 2017 |
* denotes current Printer's Number